Allernest

Formicum Acidum, Lachesis Mutus, Luffa Operculata. Petroleum, Rhus Toxicodebdron, Aralai Racemosa,galphimia Glauca, Thuja Occidentalis, Urtica Dicica And Cardiospermum

Marco Pharma International Llc.
Human Otc Drug
NDC 60986-1003

Allernest also known as Formicum Acidum, Lachesis Mutus, Luffa Operculata. Petroleum, Rhus Toxicodebdron, Aralai Racemosa,galphimia Glauca, Thuja Occidentalis, Urtica Dicica And Cardiospermum is a human otc drug labeled by 'Marco Pharma International Llc.'. National Drug Code (NDC) number for Allernest is 60986-1003. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Allernest drug includes Aralia Racemosa Root - 4 [hp_X]/mL Cardiospermum Halicacabum Flowering Top - 3 [hp_X]/mL Formic Acid - 12 [hp_X]/mL Galphimia Glauca Flowering Top - 4 [hp_X]/mL Kerosene - 6 [hp_X]/mL Lachesis Muta Venom - 8 [hp_X]/mL Luffa Operculata Fruit - 6 [hp_X]/mL Thuja Occidentalis Leafy Twig - 4 [hp_X]/mL Toxicodendron Pubescens Leaf - 6 [hp_X]/mL Urtica Dioica - 4 [hp_X]/mL . The currest status of Allernest drug is Active.

Drug Information:

Drug NDC:	60986-1003
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Allernest
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Formicum Acidum, Lachesis Mutus, Luffa Operculata. Petroleum, Rhus Toxicodebdron, Aralai Racemosa,galphimia Glauca, Thuja Occidentalis, Urtica Dicica And Cardiospermum
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Marco Pharma International Llc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ARALIA RACEMOSA ROOT - 4 [hp_X]/mL CARDIOSPERMUM HALICACABUM FLOWERING TOP - 3 [hp_X]/mL FORMIC ACID - 12 [hp_X]/mL GALPHIMIA GLAUCA FLOWERING TOP - 4 [hp_X]/mL KEROSENE - 6 [hp_X]/mL LACHESIS MUTA VENOM - 8 [hp_X]/mL LUFFA OPERCULATA FRUIT - 6 [hp_X]/mL THUJA OCCIDENTALIS LEAFY TWIG - 4 [hp_X]/mL TOXICODENDRON PUBESCENS LEAF - 6 [hp_X]/mL URTICA DIOICA - 4 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	18 Nov, 2011
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	24 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Marco Pharma International LLC.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UNII:	T90W4582DU MZP2508BRR 0YIW783RG1 93PH5Q8M7E 1C89KKC04E VSW71SS07I C4MO6809HU 1NT28V9397 6IO182RP7A 710FLW4U46
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
60986-1003-3	50 mL in 1 BOTTLE, GLASS (60986-1003-3)	27 Feb, 2018	N/A	No
60986-1003-4	100 mL in 1 BOTTLE, GLASS (60986-1003-4)	27 Feb, 2018	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Allernest

Formicum Acidum & more..

Liquid
Marco Pharma International LLC.
NDC: 60986-1003

Purpose:

Purpose relief of mild allergic reactions.

Product Elements:

Allernest formicum acidum, lachesis mutus, luffa operculata. petroleum, rhus toxicodebdron, aralai racemosa,galphimia glauca, thuja occidentalis, urtica dicica and cardiospermum water alcohol formic acid formic acid lachesis muta venom lachesis muta venom luffa operculata fruit luffa operculata fruit kerosene kerosene toxicodendron pubescens leaf toxicodendron pubescens leaf aralia racemosa root aralia racemosa root galphimia glauca flowering top galphimia glauca flowering top thuja occidentalis leafy twig thuja occidentalis leafy twig urtica dioica urtica dioica cardiospermum halicacabum flowering top cardiospermum halicacabum flowering top

Indications and Usage:

Suggested use adults: in acute disorders, take 10 drops every 15 minutes on the tongue or with water until improvement if felt, then take 10 drops less frequently. to maintain balance, take 15 drops three times daily. children receive 1/2 of the adult amount.

Warnings:

Warnings if pregnant or breast-feeding, consult a health professional before use.

Dosage and Administration:

(read suggested use section)

Package Label Principal Display Panel:

Allernest_n1s084_n1l084

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.